C4 Therapeutics (CCCC) Capital Expenditures Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 375.00% |
| Sep 30, 2025 | 76.61% |
| Jun 30, 2025 | 2,161.54% |
| Dec 31, 2024 | 99.74% |
| Sep 30, 2024 | -87.12% |
| Jun 30, 2024 | -51.85% |
| Dec 31, 2023 | -56.11% |
| Sep 30, 2023 | 173.17% |
| Jun 30, 2023 | -99.13% |
| Mar 31, 2023 | 13.95% |
| Dec 31, 2022 | -1,000.92% |
| Jun 30, 2022 | 314.73% |
| Mar 31, 2022 | -59.14% |
| Dec 31, 2021 | -82.97% |
| Jun 30, 2021 | 1,085.71% |
| Mar 31, 2021 | 3,408.33% |
| Dec 31, 2020 | -48.84% |